UA19149A - Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу - Google Patents

Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу

Info

Publication number
UA19149A
UA19149A UA4356543A UA4356543A UA19149A UA 19149 A UA19149 A UA 19149A UA 4356543 A UA4356543 A UA 4356543A UA 4356543 A UA4356543 A UA 4356543A UA 19149 A UA19149 A UA 19149A
Authority
UA
Ukraine
Prior art keywords
carbacephalosporin
crystalline
preparation
monohydrate form
crystalline form
Prior art date
Application number
UA4356543A
Other languages
English (en)
Russian (ru)
Inventor
Елейн Пасіні Керол
Элейн Пасини Керол
Original Assignee
Елі Ліллі Енд Компані
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані, Эли Лилли Энд Компани filed Critical Елі Ліллі Енд Компані
Publication of UA19149A publication Critical patent/UA19149A/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Винахід відноситься до способу одержання нової кристалічної форми антибіотика цефалоспоринового ряду, а саме кристалічного моногідрата 1-карбаце-фалоспорину формули , який знаходить застосування в медицині. Метою винаходу є створення нової кристалічної форми цефалоспорину, який має вищу стійкість в умовах вологості.
UA4356543A 1987-10-06 1988-10-05 Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу UA19149A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10576687A 1987-10-06 1987-10-06

Publications (1)

Publication Number Publication Date
UA19149A true UA19149A (uk) 1997-12-25

Family

ID=22307671

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4356543A UA19149A (uk) 1987-10-06 1988-10-05 Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу

Country Status (32)

Country Link
EP (1) EP0311366B1 (uk)
JP (1) JP2641745B2 (uk)
KR (1) KR970002637B1 (uk)
CN (1) CN1029966C (uk)
AR (1) AR248407A1 (uk)
AT (1) ATE103916T1 (uk)
AU (1) AU598155B2 (uk)
BG (1) BG47036A3 (uk)
CA (1) CA1334970C (uk)
CS (1) CS270594B2 (uk)
DD (1) DD273634A5 (uk)
DE (1) DE3888913T2 (uk)
DK (1) DK170070B1 (uk)
EG (1) EG18529A (uk)
ES (1) ES2063049T3 (uk)
FI (1) FI884554L (uk)
HK (1) HK15497A (uk)
HU (1) HU206348B (uk)
IE (1) IE62108B1 (uk)
IL (1) IL87905A (uk)
MX (1) MX13277A (uk)
MY (1) MY104063A (uk)
NO (1) NO884416L (uk)
NZ (1) NZ226450A (uk)
OA (1) OA08958A (uk)
PH (1) PH31002A (uk)
PL (1) PL152022B1 (uk)
PT (1) PT88662B (uk)
SU (1) SU1731058A3 (uk)
UA (1) UA19149A (uk)
YU (1) YU46699B (uk)
ZA (1) ZA887409B (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD280112A5 (de) * 1987-10-07 1990-06-27 ����@����@���@��������@���������@�������@�������k�� Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
US6001996A (en) * 1995-05-11 1999-12-14 Eli Lilly And Company Complexes of cephalosporins and carbacephalosporins with parabens
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
AR035533A1 (es) 2001-01-26 2004-06-02 Schering Corp Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
MXPA04002573A (es) 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
EP1601668B1 (en) 2003-03-07 2008-08-27 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
CA2517572C (en) 2003-03-07 2011-12-13 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
DD280112A5 (de) * 1987-10-07 1990-06-27 ����@����@���@��������@���������@�������@�������k�� Verfahren zur herstellung kristalliner formen eines 1-carbacephalosporins

Also Published As

Publication number Publication date
YU46699B (sh) 1994-04-05
DE3888913T2 (de) 1994-08-11
DD273634A5 (de) 1989-11-22
BG47036A3 (bg) 1990-04-16
DK553788A (da) 1989-04-07
DE3888913D1 (de) 1994-05-11
IE883015L (en) 1989-04-06
FI884554A7 (fi) 1989-04-07
IL87905A0 (en) 1989-03-31
CN1029966C (zh) 1995-10-11
PL275093A1 (en) 1989-05-02
AR248407A1 (es) 1995-08-18
NO884416D0 (no) 1988-10-05
DK553788D0 (da) 1988-10-04
NZ226450A (en) 1990-05-28
AU598155B2 (en) 1990-06-14
HUT48884A (en) 1989-07-28
PT88662A (pt) 1988-11-01
CA1334970C (en) 1995-03-28
HK15497A (en) 1997-02-14
SU1731058A3 (ru) 1992-04-30
PT88662B (pt) 1992-12-31
MX13277A (es) 1993-11-01
FI884554A0 (fi) 1988-10-04
EP0311366A1 (en) 1989-04-12
FI884554L (fi) 1989-04-07
JPH01128983A (ja) 1989-05-22
NO884416L (no) 1989-04-07
ATE103916T1 (de) 1994-04-15
MY104063A (en) 1993-11-30
KR970002637B1 (ko) 1997-03-07
CS270594B2 (en) 1990-07-12
HU206348B (en) 1992-10-28
CN1032793A (zh) 1989-05-10
PH31002A (en) 1997-12-23
EG18529A (en) 1993-04-30
PL152022B1 (en) 1990-10-31
AU2337288A (en) 1989-04-06
IE62108B1 (en) 1994-12-14
CS666688A2 (en) 1989-11-14
YU184588A (en) 1990-02-28
JP2641745B2 (ja) 1997-08-20
OA08958A (en) 1990-11-30
KR890006644A (ko) 1989-06-15
IL87905A (en) 1992-06-21
ZA887409B (en) 1990-06-27
EP0311366B1 (en) 1994-04-06
ES2063049T3 (es) 1995-01-01
DK170070B1 (da) 1995-05-15

Similar Documents

Publication Publication Date Title
UA19149A (uk) Спосіб одержаhhя кристалічhого моhогідратhої форми 1-карбацефалоспориhу
FR2601014B1 (fr) Hydrate cristallin de cephalosporine orale, sa composition et son procede de preparation
HUT47022A (en) Process for production of medical compositions
FR2624865B1 (fr) Procede de production de polybutenes
AU540912B2 (en) Production of crystalline aluminosilicate
HUT51485A (en) Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions
AU2271188A (en) Process for production of sodium cyanide
FI890889A7 (fi) Kallikreinin tuottaminen
PT86631A (pt) Process for the preparation of a novel crystalline form of potassium clavulanate
DE69319296D1 (de) Verfahren zur Reinigung von roher Clavulansäure
UA6022A1 (uk) СПОСІБ ОТРИМАННЯ ЦИКЛОАЛКОМЕДІВ (8-beta)-1АЛКІЛ-6-(ЗАМІЩЕНОГО) ЕРГОЛІНУ АБО ЇХ ФАРМАЦЕВТИЧНО ПРИДАТНИХ КИСЛОТНО-АДИТИВНИХ СОЛЕЙ
PT87503A (pt) Process for the preparation of new cathecolamine by products
FI880842A0 (fi) Menetelmä kiteisen kefeemisulfaatin valmistamiseksi
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
GR1002384B (el) Μεθοδος παρασκευης παραγωγων υποκατεστημενου στυρολιου.
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
FR2635334B1 (fr) Procede de production d'acide lactique par fermentation
PT87564A (pt) Process for preparing substituted vinylcephalosporins useful as medicaments
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
PT88431A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents
HUT49622A (en) Process for producing derivatives of phosphoric acid
FI891191A7 (fi) Menetelmä 3-eksometyleeni-kefam-johdannaisten valmistamiseksi
TNSN86165A1 (fr) Nouveaux ortho-anisamides, leur procede d'obtention et leurs applications therapeutiques
PT78347A (en) Process for preparing novel penem compounds and pharmaceutical compositions containing them